Home › NCT06115772

Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study

Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma (PAP-OP)

Who can join

Ages 18 and older · Women · Healthy volunteers welcome

Inclusion Criteria:

* \* Female patients with diagnosed HPV(+)OPSCC seen at the Mayo Clinic, Rochester

  * Age ≥ 18
  * Female partners of Mayo Clinic patients with diagnosed HPV(+)OPSCC
  * Patient has given permission to give his/her blood/saliva sample for research testing
  * Ability to complete questionnaire(s) by themselves or with assistance

Exclusion Criteria:

* \* HPV(-) OPSCC

  * Unable to provide informed consent
  * Unwilling to attend screening visit at Mayo Clinic site, if indicated
  * Unwilling/unable to complete surveys electronically

About the study

This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV).

What is being tested

• Non-Interventional Study (other)

Sponsor: Mayo Clinic · Participants: 154 · Started: Nov 1, 2022

Contact the study team

Official record on ClinicalTrials.gov — NCT06115772

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.